Outcomes-Based Agreements
Toronto, December 13, 2018 – Neil Grubert and MORSE Consulting are pleased to announce the release of a new report entitled Pharmaceutical Managed Entry Agreements – Lessons Learned from Europe, the United States, Canada, and Australia. A performance or outcomes-based agreement (OBA) tracks the effectiveness of a drug in a defined patient population over a specified period of time and directly links the price or reimbursement of the product to…
Panel 5: Patient Support Programs Panel Description: This session will help participants develop a better understanding of why PSPs are well-suited to support the development of outcomes-based agreements. It will suggest effective ways that PSPs can be developed to support data collection for HTA. Finally, current pCPA perspectives on PSPs and the opportunity for data collection within programs will be explored by this panel. Moderator: Allison Wills Panellists: Sang…
Optimizing Alberta’s Health Data: Innovative Collaboration in Real World Evidence (RWE) Generation
Optimizing Alberta’s Health Data: Innovative Collaboration in Real World Evidence (RWE) Generation Alberta has long been known for its leadership in the energy sector and for its entrepreneurial spirit reputation for being a trail blazer across the political spectrum. Historically, Alberta’s economic engine has been its natural resources. The other major Alberta resource that is less well known is health data. Much like its natural resources, data needs to…
Contact Us
MORSE Consulting Inc.
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
Outcomes-Based Agreements | MORSE Consulting Inc.
